Phosphodiesterase 4 Inhibition Attenuates Diet-Induced Obesity and Activates BAT Thermogenic Pathways Through Central Mechanisms
Diabetes · 15.09.2026
DOI: 10.2337/db25-1135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 15.09.2026. Verfasst von Hellen Veida-Raposo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES), FAEPA-HCFMRP-USP, National Council for Scientific and Technological Development (CNPq).
Abstract (Originalsprache)
Obesity is marked by chronic low-grade inflammation and impaired thermogenic function of brown adipose tissue (BAT), contributing to decreased energy expenditure. BAT dissipates energy through uncoupling protein 1 (UCP1)-mediated thermogenesis, a process suppressed in obesity. Phosphodiesterase 4 (PDE4) inhibition reduces inflammation by decreasing TNF-α release, and it has been linked to protection against metabolic dysfunction. Here, we investigated the effects of rolipram, a selective PDE4 inhibitor, in a model of diet-induced obesity. Male C57Bl/6 mice were fed a chow or high-fat diet (HFD; 60% fat) for 10 weeks and treated daily with rolipram (2 mg/kg, subcutaneous) or vehicle from week 8 on. Rolipram reduced body weight and adiposity in HFD-fed mice. It also enhanced BAT function, increasing thermogenic gene expression, UCP1 protein, noradrenaline content, and BAT temperature. PDE4 inhibition increased energy expenditure and heat production without altering locomotor activity. Corroborating these data, rolipram elevated cFOS expression and increased membrane excitability in neurons of the hypothalamic paraventricular nucleus, suggesting activation of hypothalamic pathways involved in energy balance and thermoregulation. These findings show that PDE4 inhibition attenuates diet-induced obesity by stimulating BAT thermogenesis and energy expenditure at least partially through central mechanisms, supporting PDE4 as a promising target for obesity treatment. ARTICLE HIGHLIGHTS Metabolic alterations in obesity encompass impaired thermogenesis and sympathetic activity, underscoring the need for new metabolic targets to treat this disease. This study tested whether inhibition of PDE4 by rolipram enhances energy expenditure and brown adipose tissue activity. Rolipram reduced body weight and adiposity and increased brown adipose tissue temperature, UCP1 protein levels, noradrenaline levels, and enhanced excitability of hypothalamic paroventricular nucleus neurons. These findings suggest that central PDE4 inhibition promotes brown adipose tissue thermogenic activity and contributes to the metabolic effects of rolipram.
Autor:innen und Institutionen
- Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
- Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
- Department of Biomolecular Sciences, Faculty of Pharmaceutical Sciences of Ribeirão, Preto University of São Paulo, São Paulo, Brazil.
- Department of Biochemistry, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
ORCID-Profile: Hellen Veida-Raposo, Francisco José Albuquerque de Paula, Lucila Leico K Elias
Förderung
- Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)
- FAEPA-HCFMRP-USP
- National Council for Scientific and Technological Development (CNPq)
- Funda de Ampar Pesquisa d Estado de S Paul
Zitieren
APA
Veida-Raposo, H., de Andrade, M. A. M., Zarpellon, P. S. B., Seixas, M. S., Duarte, L. M., Alarcón-Yempén, R. E., de Jesus, A. A., Alberici, L. C., Leão, R. M., Antunes-Rodrigues, J., de Paula, F. J. A., & Elias, L. L. K. (2026). Phosphodiesterase 4 Inhibition Attenuates Diet-Induced Obesity and Activates BAT Thermogenic Pathways Through Central Mechanisms. Diabetes. https://doi.org/10.2337/db25-1135
Vancouver
Veida-Raposo H, de Andrade MAM, Zarpellon PSB, Seixas MS, Duarte LM, Alarcón-Yempén RE, et al. Phosphodiesterase 4 Inhibition Attenuates Diet-Induced Obesity and Activates BAT Thermogenic Pathways Through Central Mechanisms. Diabetes. 2026. doi:10.2337/db25-1135
BibTeX
@article{VeidaRaposo2026,
author = {Veida-Raposo, Hellen and de Andrade, Maria Amélia Montenegro and Zarpellon, Patrik Saul Barbosa and Seixas, Michele de Souza and Duarte, Luiza Mendonça and Alarcón-Yempén, Rosa Elvira and de Jesus, Aline Alves and Alberici, Luciane Carla and Leão, Ricardo Maurício and Antunes-Rodrigues, José and de Paula, Francisco José Albuquerque and Elias, Lucila Leico K},
title = {Phosphodiesterase 4 Inhibition Attenuates Diet-Induced Obesity and Activates BAT Thermogenic Pathways Through Central Mechanisms},
journal = {Diabetes},
year = {2026},
doi = {10.2337/db25-1135}
}
EUVIMED